VEGFA and diabetic kidney disease: Hirudin has been reported to be useful to preventing diabetic nephropathy (DN) and diabetic peripheral neuropathy, and the potential molecular mechanisms mainly include the inhibition of HIF-1α/VEGF and p38 MAPK/NF-κB pathways, or the activation of NRF-2/HO-1 pathways.